ICU
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$2.96
+1.72%Aug 12, 2026, 23:58 UTC
SeaStar Medical Holding Corporation expanded adoption of its QUELIMMUNE product to 20 of 50 premier children's hospitals, targeting 25 by year-end.
Source:Aug 12, 2026, 20:05 UTC
SeaStar Medical reported its second quarter 2026 financial results, with net revenue up 82% versus the second quarter of 2025, and added three top-rated children's hospitals to its QUELIMMUNE pediatric acute kidney injury customer base.
Source: